SEARCH

SEARCH BY CITATION

References

  • Böhle, A., Gerdes, J., Ulmer, A. J., Hofstetter, A. G. and Flad, H.-D., Effect of local bacillus-Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J. Urol., 144, 5358 (1990).
  • Bruno, S., Macchi, A. M., Semino, C., Meta, M., Ponte, M., Varaldo, M., Curotto, A., Ferlazzo, G., Decensi, A. and Melioli, G., Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer. Cancer Immunol. Immunother., 42, 4754 (1996).
  • Cilento, B. G., Freeman, M. R., Schneck, E. X., Retik, A. B. and Atala, A., Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J. Urol., 152, 665670 (1994).
  • Darrow, T. L., Slingluff, C. L. and Seigler, H. F., The role of HLA-class-I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. J. Immunol., 142, 33293335 (1989).
  • De Boer, E. C., Jong, W. H., Van Der Meijden, A. P., Steerenberg, P. A., Witjes, J. A., Vegt, P. D., Debruyne, F. M. and Ruitenberg, E. J., Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guerin. Cancer Immunol. Immunother., 33, 411416 (1991).
  • Dubeau, L. and Jones, P. A., Growth of normal and neoplastic urothelium and response to epidermal growth in a defined serum-free medium. Cancer Res., 47, 21072112 (1987).
  • Finke, J. H., Rayman, P., Hart, L., Alexander, J. P., Edinger, M. G., Tubbs, R. R., Klein, E., Tuason, L. and Bukowski, R. M., Characterization of tumor-infiltrating lymphocyte sub-sets from human renal-cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation. J. Immunother., 15, 91104 (1994).
  • Haas, G. P., Solomon, D. and Rosenberg, S. A., Tumor-infiltrating lymphocytes from non-renal urological malignancies. Cancer Immunol. Immunother., 30, 342350 (1990).
  • Hom, S. S., Topalian, S. L., Simonis, T., Mancini, M. and Rosenberg, S. A., Common expression of melanoma-tumor-associated antigens recognized by human tumor-infiltrating lymphocytes: analysis by human lymphocytes antigen restriction. J. Immunother., 10, 153164 (1991).
  • Ioannides, C. G., Freedman, R. S., Platsoucas, C. D., Rashed, S. and Kim, Y. P., Cytotoxic T-cell clones isolated from ovarian-tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J. Immunol., 146, 17001707 (1991).
  • Jackson, A. M., Alexandrof, A. B., Prescott, S., James, K. and Chisholm, G. D., Expression of adhesion molecules by bladder-cancer cells: modulation by interferon-gamma and tumor necrosis factor-alpha. J. Urol., 148, 15831586 (1992).
  • Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T. and Rosenberg, S. A., Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. nat. Acad. Sci. (Wash.), 91, 64586462 (1994).
  • Kradin, R. L., Boyle, L. A., Preffer, E. L., Callahan, R. J., Barlai-Kovach, M., Strauss, H. W., Dubinett, S. and Kurnick, J. T., Tumor-derived interleukin-2–dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol. Immunother., 24, 7685 (1987).
  • Lamm, D. L., Blumenstein, B. A., Crawford, D., Montie, J. E., Scardino, P., Grossman, H. B., Stanisic, T. H., Smith, J. A., Sullivan, J., Sarosdy, M. E., Crissman, J. D. and Coltman, C. A., A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder. New. Engl. J. Med., 325, 12051209 (1991).
  • Mackensen, A., Carcelain, G., Viel, S., Raynal, M.-C., Michalak, H., Triebel, E., Bosq, J. and Hercend, T., Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. clin. Invest., 93, 13971402 (1994).
  • Moll, R., Achtstätter, T., Becht, E., Balcarova-Stander, J., Itten-sohn, M. and Franke, W. W., Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional-cell carcinoma and bladder-carcinoma cell-culture lines. Amer J. Pathol., 132, 123144 (1988).
  • Muul, L. M., Spiess, P. J., Director, E. P. and Rosenberg, S. A., Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol., 138, 989995 (1987).
  • Narayan, P., Transitional-cell carcinoma. J. Urol., 156, 389390 (1996).
  • Peters, L. C., Brandhorst, I. S. and Hanna, M. G., Preparation of immuno-therapeutic autologous tumor-cell vaccines from solid tumors. Cancer Res., 39, 13531360 (1979).
  • Prescott, S., James, K., Hargreave, T. B., Chisholm, G. D. and Smyth, J. E., Intravesical Evans-strain BCG therapy: quantitative immunohistochemi-cal analysis of the immune response within the bladder wall. J. Urol., 147, 16361642 (1992).
  • Rosenberg, S. A., Spiess, P. and Lafreniere, R., A new approach to the adoptive immunotherapy of cancer using tumor-infiltrating lymphocytes. Science, 233, 13181321 (1986).
  • Schwartzentruber, D. J., Solomon, D., Rosenberg, S. A. and Topalian, S. L., Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. J. Immunother., 12, 112 (1992).
  • Topalian, S. L., Muul, L. M., Solomon, D. and Rosenberg, S. A., Expansion of human tumor-infiltrating lymphocytes for use in immunotherapy trials. J. immunol. Meth., 102, 127141 (1987).
  • Topalian, S. L., Solomon, D. and Rosenberg, S. A., Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol, 142, 37143725 (1989).
  • Tsujihashi, H., Matsuda, H., Uejima, S., Akiyama, T. and Kurita, T., Immunocompetence of tissue-infiltrating lymphocytes in bladder tumors. J. Urol., 140, 890894 (1988).
  • Webb, D. S. A., Mostowski, H. S. and Gerrard, T. L., Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. J. Immunol., 146, 36823686 (1991).
  • Yoo, Y.-K., Heo, D. S., Hata, K., Thiel, D. H. V. and Whiteside, T. L., Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2. Gastroenterology, 98, 259268 (1990).
  • Zhai, Y., Yang, J. C., Kawakami, Y., Spiess, P., Wadsworth, S. C., Cardoza, L. M., Couture, L. A., Smith, A. E. and Rosenberg, S. A., Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp 100 for cancer therapy. J. Immunol., 156, 700710 (1996).